🇺🇸 FDA
Patent

US 7323459

Crystal forms, methods for their preparation and method for preparation of olanzapine

granted A61PA61P25/18

Quick answer

US patent 7323459 (Crystal forms, methods for their preparation and method for preparation of olanzapine) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P25/18